Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 31.95-10.0912.99274.74-63.19

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is 31.95 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202431.95
Mar2023-10.09
Mar202212.99
Mar2021274.74
Mar2020-63.19

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 31.95
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74
Positive
Mar2020 -63.19 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹193.5 Cr 46.3% 49.8% 11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

46.3%

49.8%

11.6%

SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses